WA
GILD icon

Winfield Associates’s Gilead Sciences GILD Stock Holding History

Winfield Associates’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$215K Sell
3,620
-40
-1% -$2.56K 0.08% 147
2021
Q4 		$266K Buy
3,660
+565
+18% +$38.9K 0.09% 137
2021
Q3 		$216K Buy
+3,095
New +$217K 0.08% 142
2018
Q1 		– Sell
-305
Closed -$23K – 322
2017
Q4 		$23K Sell
305
-15
-5% -$1.14K 0.01% 285
2017
Q3 		$26K Sell
320
-29
-8% -$2.22K 0.01% 257
2017
Q2 		$24K Buy
349
+229
+191% +$15.2K 0.01% 263
2017
Q1 		$8K Sell
120
-960
-89% -$67.5K ﹤0.01% 411
2016
Q4 		$77K Sell
1,080
-2,355
-69% -$175K 0.05% 155
2016
Q3 		$272K Sell
3,435
-5,369
-61% -$436K 0.17% 99
2016
Q2 		$734K Sell
8,804
-170
-2% -$15.1K 0.48% 56
2016
Q1 		$824K Sell
8,974
-536
-6% -$48.3K 0.56% 47
2015
Q4 		$962K Sell
9,510
-1,525
-14% -$159K 0.64% 41
2015
Q3 		$1.08M Sell
11,035
-950
-8% -$106K 0.81% 38
2015
Q2 		$1.4M Hold
11,985
– – 0.96% 31
2015
Q1 		$1.18M Sell
11,985
-1,545
-11% -$157K 0.82% 36
2014
Q4 		$1.27M Sell
13,530
-2,730
-17% -$282K 0.94% 29
2014
Q3 		$1.73M Buy
16,260
+1,675
+11% +$164K 1.29% 16
2014
Q2 		$1.21M Buy
14,585
+1,550
+12% +$121K 0.88% 34
2014
Q1 		$924K Buy
+13,035
New +$1.02M 0.76% 43

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Winfield Associates's GILD Position: Q1 2022 in Review

Winfield Associates reduced its Gilead Sciences (GILD) stake by 1.1% in Q1 2022, selling an estimated $2.56K and leaving 3,620 shares worth $215K. The position accounts for 0.08% of the portfolio, ranked #147.

Winfield Associates first reported a position in GILD in Q1 2014 and has held it in 19 quarters since. The position peaked at $1.73M in Q3 2014. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

  • Winfield Associates held 3,620 shares of Gilead Sciences worth $215K as of Q1 2022.
  • Winfield Associates sold 40 Gilead Sciences shares in Q1 2022, an estimated $2.56K.
  • Gilead Sciences made up 0.08% of Winfield Associates's portfolio in Q1 2022, its #147 holding.
  • Winfield Associates first reported a position in Gilead Sciences in Q1 2014 and has held it in 19 quarters since.
  • Winfield Associates's Gilead Sciences position peaked at $1.73M in Q3 2014.
  • 1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Winfield Associates's 13F filing for Q1 2022, filed 5 Apr 2022.